Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT-1207 Tablets in Mild to Moderate Primary Hypertension
CTR20220993Phase 2Completed
- Sponsor
- Liaoning Green Biological Pharmaceutical Group
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of MT-1207 in essential hypertension, sponsored by Liaoning Green Biological Pharmaceutical Group. Started Apr 2022; status: completed.
02
Drugs
MT-1207
03
Conditions
essential hypertension
Beyond the preview
Go deeper on CTR20220993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220993.